Machine Learning To Stratify Methicillin-Resistant Staphylococcus aureus Risk among Hospitalized Patients with Community-Acquired Pneumonia-Reference-Cited by-同舟云学术

Machine Learning To Stratify Methicillin-Resistant Staphylococcus aureus Risk among Hospitalized Patients with Community-Acquired Pneumonia

Published:2023-01-24 Issue:1 Volume:67 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Rhodes Nathaniel J.¹²³^ORCID,Rohani Roxane¹²³^ORCID,Yarnold Paul R.⁴^ORCID,Pawlowski Anna E.⁵,Malczynski Michael⁶,Qi Chao⁷,Sutton Sarah H.⁸⁹,Zembower Teresa R.⁷⁸⁹,Wunderink Richard G.¹⁰^ORCID

Affiliation:

1. Department of Pharmacy Practice, Midwestern University, Chicago College of Pharmacy, Downers Grove, Illinois, USA

2. Pharmacometrics Center of Excellence, Midwestern University, Downers Grove, Illinois, USA

3. Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois, USA

4. Optimal Data Analysis, LLC, Chicago, Illinois, USA

5. Clinical Translational Sciences Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

6. Department of Microbiology, Northwestern Memorial Hospital, Chicago, Illinois, USA

7. Department of Pathology, Northwestern Memorial Hospital, Chicago, Illinois, USA

8. Division of Infectious Diseases, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

9. Healthcare Epidemiology and Infection Prevention, Northwestern Memorial Hospital, Chicago, Illinois, USA

10. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is an uncommon but serious cause of community-acquired pneumonia (CAP). A lack of validated MRSA CAP risk factors can result in overuse of empirical broad-spectrum antibiotics.

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

HHS | NIH | National Center for Advancing Translational Sciences

American Association of Colleges of Pharmacy

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.01023-22

Reference37 articles.

1. Sutton J, Steiner C. 2016. Hospital-, health care-, and community-acquired MRSA: estimates from California hospitals, 2013. Agency for Healthcare Research and Quality, Rockville, MD.

2. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America

3. Staphylococcus aureusCommunity-acquired Pneumonia: Prevalence, Clinical Characteristics, and Outcomes

4. Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia

5. Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence and prescription of antibiotic therapy: present and future;Expert Review of Anti-infective Therapy;2024-08-18

2. Artificial intelligence applications in the diagnosis and treatment of bacterial infections;Frontiers in Microbiology;2024-08-06

3. Improving Risk Prediction of Methicillin-Resistant Staphylococcus aureus Using Machine Learning Methods With Network Features: Retrospective Development Study;JMIR AI;2024-05-16

4. Individual meropenem epithelial lining fluid and plasma PK/PD target attainment;Antimicrobial Agents and Chemotherapy;2023-12-14

5. Antibiotic treatment of community-acquired and hospital-acquired pneumonia;Medizinische Klinik - Intensivmedizin und Notfallmedizin;2023-07-05